Skip to main content
Log in

Is Alteplase (t-PA) More Cost-Effective than Streptokinase?

  • Current Comment
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Goel V, Naylor DC. Potential cost-effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction. Canadian Journal of Cardiology 8: 31–38, 1992

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanchez, L.A. Is Alteplase (t-PA) More Cost-Effective than Streptokinase?. PharmacoEconomics 2, 427–428 (1992). https://doi.org/10.2165/00019053-199202050-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199202050-00011

Keywords

Navigation